Chronic Obstructive Pulmonary Disease Market Size To Hit US$ 18,256.1 Million By 2033
According to IMARC Group’s latest report, titled “ Chronic Obstructive Pulmonary Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033 ”, The 7 major chronic obstructive pulmonary disease markets reached a value of US$ 13,061.7 Million in 2022. Looking forward, IMARC Group expects the 7MM to reach US$ 18,256.1 Million by 2033, exhibiting a growth rate (CAGR) of 3.08% during 2023-2033.This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form. Industry Definition and Application: Chronic obstructive pulmonary disease (COPD) stands for a long-term respiratory condition marked by unceasing airflow restriction, mainly caused by airway inflammation and lung tissue damage. Symptoms like breathlessness, wheezing, chest discomfort, chronic coughing, and overproduction of mucus often lead to difficulties in breathing, making e...